Oscillatory glucose flux in INS 1 pancreatic beta cells: A self-referencing microbiosensor study

Jin Shi, Birck Nanotechnology Center, Bindley Bioscience Center, Purdue University
Eric McLamore, Birck Nanotechnology Center, Bindley Bioscience Center, Purdue University
David Jaroch, Birck Nanotechnology Center, Bindley Bioscience Center, Purdue University
Jonathan C. Claussen, Birck Nanotechnology Center, Bindley Bioscience Center, Purdue University
Raghavendra Mirmira, Indiana University-Purdue University Indianapolis
Jenna Rickus, Birck Nanotechnology Center, Bindley Bioscience Center, Purdue University
D. Marshall Porterfield, Birck Nanotechnology Center, Bindley Bioscience Center, Purdue University

Date of this Version

4-15-2011

Citation

Analytical Biochemistry Volume 411, Issue 2, 15 April 2011, Pages 185–193

Abstract

Signaling and insulin secretion in beta cells have been reported to demonstrate oscillatory modes, with abnormal oscillations associated with type 2 diabetes. We investigated cellular glucose influx in beta cells with a self-referencing (SR) microbiosensor based on nanomaterials with enhanced performance. Dose-response analyses with glucose and metabolic inhibition studies were used to study oscillatory patterns and transporter kinetics. For the first time, we report a stable and regular oscillatory uptake of glucose (averaged period 2.9 +/- 0.6 min), which corresponds well with an oscillator model. This oscillatory behavior is part of the feedback control pathway involving oxygen, cytosolic Ca(2+)/ATP, and insulin secretion (periodicity approximately 3 min). Glucose stimulation experiments show that the net Michaelis-Menten constant (6.1 +/- 1.5 mM) is in between GLUT2 and GLUT9. Phloretin inhibition experiments show an EC(50) value of 28 +/- 1.6 mu M phloretin for class I GLUT proteins and a concentration of 40 +/- 0.6 mu M phloretin caused maximum inhibition with residual nonoscillating flux, suggesting that the transporters not inhibited by phloretin are likely responsible for the remaining nonoscillatory uptake, and that impaired uptake via GLUT2 may be the cause of the oscillation loss in type 2 diabetes. Transporter studies using the SR microbiosensor will contribute to diabetes research and therapy development by exploring the nature of oscillatory transport mechanisms. (C) 2010 Elsevier Inc. All rights reserved.

Discipline(s)

Nanoscience and Nanotechnology

 

Share